en

PRODUCT DETAIL

TEPEZZA 500 mg prášok na koncentrát na infúzny roztok

Code 0745F
MA number EU/1/25/1941/001
Product Form: plc ifc 1x500 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Amgen Europe B.V., Netherland
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AG ?
L04AG13 Teprotumumab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 19.06.2025
Validity: 19.06.2030
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 27.07.2025
eu-flag.png sk-flag.png